Page 137 - Read Online

Page 20 of 23 Gutierrez et al. Microbiome Res Rep 2023;2:36 https://dx.doi.org/10.20517/mrr.2023.37

between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol Lett 2015;362:fnv176. DOI PubMed
103. Glover JS, Ticer TD, Engevik MA. Characterizing the mucin-degrading capacity of the human gut microbiota. Sci Rep 2022;12:8456.
DOI PubMed PMC
104. Fang J, Wang H, Zhou Y, Zhang H, Zhou H, Zhang X. Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis.
Exp Mol Med 2021;53:772-87. DOI PubMed PMC
105. Crouch LI, Liberato MV, Urbanowicz PA, et al. Prominent members of the human gut microbiota express endo-acting O-glycanases
to initiate mucin breakdown. Nat Commun 2020;11:4017. DOI
106. Raba G, Luis AS. Mucin utilization by gut microbiota: recent advances on characterization of key enzymes. Essays Biochem
2023;67:345-53. DOI PubMed PMC
107. Marcobal A, Southwick AM, Earle KA, Sonnenburg JL. A refined palate: bacterial consumption of host glycans in the gut.
Glycobiology 2013;23:1038-46. DOI PubMed PMC
108. Turroni F, Bottacini F, Foroni E, et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-
derived glycan foraging. Proc Natl Acad Sci U S A 2010;107:19514-9. DOI PubMed PMC
109. Ruiz L, Gueimonde M, Couté Y, et al. Evaluation of the ability of Bifidobacterium longum to metabolize human intestinal mucus.
FEMS Microbiol Lett 2011;314:125-30. DOI
110. Katayama T, Sakuma A, Kimura T, et al. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-alpha-L-fucosidase
(AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J Bacteriol 2004;186:4885-93. DOI PubMed PMC
111. Egan M, Motherway MO, Kilcoyne M, et al. Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with
Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol 2014;14:282. DOI PubMed PMC
112. Takada H, Katoh T, Sakanaka M, Odamaki T, Katayama T. GH20 and GH84 β-N-acetylglucosaminidases with different linkage
specificities underpin mucin O-glycan breakdown capability of Bifidobacterium bifidum. J Biol Chem 2023;299:104781. DOI
PubMed PMC
113. Gibson GR, Beatty ER, Wang X, Cummings JH. Selective stimulation of bifidobacteria in the human colon by oligofructose and
inulin. Gastroenterology 1995;108:975-82. DOI PubMed
114. Zhou JS, Gopal PK, Gill HS. Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus
(HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro. Int J Food Microbiol 2001;63:81-90. DOI
115. Subramani DB, Johansson ME, Dahlén G, Hansson GC. Lactobacillus and Bifidobacterium species do not secrete protease that
cleaves the MUC2 mucin which organises the colon mucus. Benef Microbes 2010;1:343-50. DOI
116. Derrien M, van Passel MW, van de Bovenkamp JH, Schipper RG, de Vos WM, Dekker J. Mucin-bacterial interactions in the human
oral cavity and digestive tract. Gut Microbes 2010;1:254-68. DOI PubMed PMC
117. Norin KE, Gustafsson BE, Lindblad BS, Midtvedt T. The establishment of some microflora associated biochemical characteristics in
feces from children during the first years of life. Acta Paediatr Scand 1985;74:207-12. DOI PubMed
118. Midtvedt AC, Carlstedt-Duke B, Midtvedt T. Establishment of a mucin-degrading intestinal microflora during the first two years of
human life. J Pediatr Gastroenterol Nutr 1994;18:321-6. DOI
119. Karav S, Casaburi G, Frese SA. Reduced colonic mucin degradation in breastfed infants colonized by Bifidobacterium longum subsp.
infantis EVC001. FEBS Open Bio 2018;8:1649-57. DOI PubMed PMC
120. Klaassens ES, Boesten RJ, Haarman M, et al. Mixed-species genomic microarray analysis of fecal samples reveals differential
transcriptional responses of bifidobacteria in breast- and formula-fed infants. Appl Environ Microbiol 2009;75:2668-76. DOI
PubMed PMC
121. Belzer C. Nutritional strategies for mucosal health: the interplay between microbes and mucin glycans. Trends Microbiol 2022;30:13-
21. DOI PubMed
122. Desai MS, Seekatz AM, Koropatkin NM, et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and
enhances pathogen susceptibility. Cell 2016;167:1339-53.e21. DOI PubMed PMC
123. Schroeder BO, Birchenough GMH, Ståhlman M, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated
colonic mucus deterioration. Cell Host Microbe 2018;23:27-40.e7. DOI PubMed PMC
124. Yoshihara T, Oikawa Y, Kato T, et al. The protective effect of Bifidobacterium bifidum G9-1 against mucus degradation by
Akkermansia muciniphila following small intestine injury caused by a proton pump inhibitor and aspirin. Gut Microbes
2020;11:1385-404. DOI PubMed PMC
125. Mangin I, Dossou-Yovo F, Lévêque C, et al. Oral administration of viable Bifidobacterium pseudolongum strain patronus modified
colonic microbiota and increased mucus layer thickness in rat. FEMS Microbiol Ecol 2018;94:fiy177. DOI
126. Caballero-Franco C, Keller K, De Simone C, Chadee K. The VSL#3 probiotic formula induces mucin gene expression and secretion
in colonic epithelial cells. Am J Physiol Gastrointest Liver Physiol 2007;292:G315-22. DOI PubMed
127. Burger-van Paassen N, Vincent A, Puiman PJ, et al. The regulation of intestinal mucin MUC2 expression by short-chain fatty acids:
implications for epithelial protection. Biochem J 2009;420:211-9. DOI
128. Romond MB, Bezirtzoglou E, Romond C. Colonization of the Murine Gut by Bifidobacterium bifidum and Clostridium perfringens
during ageing. Microb Ecol Health Dis 1998;10:91-4. DOI
129. Romond MB, Haddou Z, Mielcareck C, Romond C. Bifidobacteria and human health: regulatory effect of indigenous bifidobacteria
on Escherichia coli intestinal colonization. Anaerobe 1997;3:131-6. DOI PubMed
130. Toumi R, Abdelouhab K, Rafa H, et al. Beneficial role of the probiotic mixture ultrabiotique on maintaining the integrity of intestinal